About: Detection rates and biologic significance of prostate cancer with PSA less than 4.0 ng/mL: observation and clinical implications from Tyrol screening project

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Detection rates and biologic significance of prostate cancer with PSA less than 4.0 ng/mL: observation and clinical implications from Tyrol screening project Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 November 2005

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в листопаді 2005 (uk) im November 2005 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en payares de 2005 (ast) scientific article published on 01 November 2005 (en)
publication date	wds:Q81476468-2420F98B-1E2E-419A-B627-6D5A2CFBD95E
publication date	2005-11-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q81476468-2DB5175B-9404-4ED8-9BC4-9A93F3A1124C
language of work or name	English
cites work	wds:Q81476468-0F2B8BF9-25FA-4127-9992-C05BBBB2F62D wds:Q81476468-0F882ADD-9FDA-4F6D-B9C1-E1815FE27C78 wds:Q81476468-297A0330-FF22-44B9-AF98-C8418BD00978 wds:Q81476468-703BAC6C-8470-4223-8092-8AB8BD608DB0 wds:Q81476468-70DA0927-8E3E-489D-A5B6-E0064C3D7FE1 wds:Q81476468-7D950C1B-0567-4487-BE82-C05A49715518 wds:Q81476468-89C4EE56-F7E4-47BC-9FD8-831E8C305EF3 wds:Q81476468-9AC11A32-9828-41A9-8125-EEE34F11B107 wds:Q81476468-9FCC9135-A5E9-4A1A-B333-68790F9BC832 wds:Q81476468-B44FEABC-5168-4B2B-9E42-16319B0807E5 wds:Q81476468-C026813B-20D0-4BDE-9302-BC0ABA9246D0 wds:Q81476468-C17E6E5C-B513-4007-8646-A947A0ADBD73 wds:Q81476468-CD17D46D-4144-439C-B609-6E6C4A98748A wds:Q81476468-D0A84244-E472-4762-B425-D81D1C34B553 wds:Q81476468-E5E22682-D1D5-46D3-BBF0-274A0EC54F96 wds:Q81476468-EB3312F7-8B15-4A02-BC99-CA249716D23F wds:Q81476468-EC0B9705-DBD6-48EC-B7F3-9295CF392BFE wds:Q81476468-F500530C-47BA-4708-A65B-E942E9786092
cites work	An evaluation of the decreasing incidence of positive surgical margins in a large retropubic prostatectomy series Comparison of contrast enhanced color Doppler targeted biopsy with conventional systematic biopsy: impact on prostate cancer detection Natural history of progression after PSA elevation following radical prostatectomy Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter Serendipity in detecting disease in low prostate-specific antigen ranges. Prostate-specific antigen levels from completely sectioned, clinically benign, whole prostates Patterns of progression in prostate cancer Prostate cancer mortality after introduction of prostate-specific antigen mass screening in the Federal State of Tyrol, Austria Potency, continence and complication rates in 1,870 consecutive radical retropubic prostatectomies Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience Selection of optimal prostate specific antigen cutoffs for early detection of prostate cancer: receiver operating characteristic curves. Early detection of prostate cancer with low PSA cut-off values leads to significant stage migration in radical prostatectomy specimens. Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng/mL and benign prostate examination. Enhancement of specificity with free PSA measurements Prostate-specific antigen cutoff of 2.6 ng/mL for prostate cancer screening is associated with favorable pathologic tumor features Prostate cancer screening in Tyrol, Austria: experience and results Prospective detection of clinically relevant prostate cancer in the prostate specific antigen range 1 to 3 ng./ml. combined with free-to-total ratio 20% or less: the Aarau experience. Competing risk analysis after radical prostatectomy for clinically nonmetastatic prostate adenocarcinoma according to clinical Gleason score and patient age Characteristics of prostate cancers detected at low PSA levels
author name string	wds:Q81476468-1CF979BE-6193-402E-AB62-40541AAE7D7E wds:Q81476468-608A452A-D50E-40EE-98C3-B074EF037EAA wds:Q81476468-9D39ABBA-1530-495E-86AC-D7AEDB312D88 wds:Q81476468-D8E8C68D-6234-4145-B82C-1C469D89B8AC
author name string	Wolfgang Horninger Georg Bartsch Ferdinand Frauscher Andreas P Berger
rdfs:label	Detection rates and biologic significance of prostate cancer with PSA less than 4.0 ng/mL: observation and clinical implications from Tyrol screening project (en) Detection rates and biologic significance of prostate cancer with PSA less than 4.0 ng/mL: observation and clinical implications from Tyrol screening project (nl)
skos:prefLabel	Detection rates and biologic significance of prostate cancer with PSA less than 4.0 ng/mL: observation and clinical implications from Tyrol screening project (en) Detection rates and biologic significance of prostate cancer with PSA less than 4.0 ng/mL: observation and clinical implications from Tyrol screening project (nl)
name	Detection rates and biologic significance of prostate cancer with PSA less than 4.0 ng/mL: observation and clinical implications from Tyrol screening project (en) Detection rates and biologic significance of prostate cancer with PSA less than 4.0 ng/mL: observation and clinical implications from Tyrol screening project (nl)
author	wds:Q81476468-9AEF00A8-0AC0-4279-B717-832369FD737C wds:Q81476468-F8638ECC-6CDD-4EB1-9AD6-04C6E00686F0 wds:Q81476468-FD269178-7947-47AE-B114-23492CB80833
author	Ashutosh Tewari Alexandre E Pelzer Jasmin Bektic
title	wds:Q81476468-67017DFC-3904-4985-A100-DEE1393B8F2C
title	Detection rates and biologic significance of prostate cancer with PSA less than 4.0 ng/mL: observation and clinical implications from Tyrol screening project (en)
page(s)	wds:Q81476468-F5EB7544-A667-4E01-8D6A-C975D3340656
page(s)	1029-1033
instance of	wds:Q81476468-6929EE5F-0A80-47A1-8BE5-753C4536DC3C
instance of	scholarly article
main subject	wds:Q81476468-AB313591-A85A-4BCA-B006-EDB3D6BC44EC
main subject	prostate cancer
PubMed ID	wds:Q81476468-21B28047-50A0-4C50-B465-CD7C4C2062BC
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/16286118
PubMed ID	16286118
published in	wds:Q81476468-43CDEE87-7A4D-4314-8AEC-4FE0EFCB3C17
published in	Urology
issue	wds:Q81476468-93F9D61C-03FB-4C77-818F-2CDF4E24812C
volume	wds:Q81476468-FA867402-149E-4E3D-8289-B4906B0A8665
issue	5
volume	66
DOI	wds:Q81476468-AF8DAF1A-CF3C-4D5F-8CAF-BBE0CBBAB661
DOI	http://dx.doi.org/10.1016/J.UROLOGY.2005.05.025
DOI	10.1016/J.UROLOGY.2005.05.025
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q81476468
is cites work of	Advancements in MR imaging of the prostate: from diagnosis to interventions A novel gene signature for molecular diagnosis of human prostate cancer by RT-qPCR. Incidence of prostate cancer in male breast cancer patients: a risk factor for prostate cancer screening How should PSA screening efforts be focused to prevent underdiagnosis and overdiagnosis of prostate cancer? Perioperative, oncological and functional outcomes of the first robotic prostatectomy program in Quebec: Single fellowship-trained surgeon's experience of 250 cases Prospective validation of %p2PSA and the Prostate Health Index, in prostate cancer detection in initial prostate biopsies of Asian men, with total PSA 4-10 ng ml-1. CCL11 (eotaxin-1): a new diagnostic serum marker for prostate cancer Prostate carcinoma Predictive Factors for Prostate Cancer in Biopsy of Patients with Prostate-Specific Antigen Levels Equal to or Less Than 4 ng/ml Oncological and functional outcomes of 722 robot-assisted radical prostatectomy (RARP) cases: The largest Canadian 5-year experience Can the Free/Total PSA Ratio Predict the Gleason Score Before Prostate Biopsy? Effect of finasteride on prostate-specific antigen
is cites work of	wds:Q24594047-15AFE854-8B84-41AD-9B26-D00FE8A590B0

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 183 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software